Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

C1'-Azacycloalkyl Hexahydrocannabinols.

Thanh C Ho1, Naoyuki Shimada1, Marcus A Tius1

  • 1Department of Chemistry, University of Hawaii at Manoa , 2545 The Mall, Honolulu, Hawaii 96822, United States.

The Journal of Organic Chemistry
|July 6, 2017
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Library Docking for Cannabinoid-2 Receptor Ligands.

Journal of medicinal chemistry·2026
Same author

Dopamine, γ-aminobutyric acid, and glutamate balance in the nucleus accumbens shell: Differential effects of cannabinoid 1 receptor agonists Δ<sup>9</sup>-Tetrahydrocannabinol, AM11101, and AM8936.

Neuropharmacology·2026
Same author

On the Discorhabdins Leading to the Aleutianamine Ring System: A One-Step in Situ Transformation Characterized Through Computational and Experimental Studies and Its Implications on Biosynthesis, Synthesis, and Pharmacology.

Angewandte Chemie (International ed. in English)·2026
Same author

Aleutianamine B, A Novel Chiral Sulfoxide Isolated from <i>Latrunculia</i> spp. and Generated via Semi-Synthesis, Exhibits Selectivity for Ovarian Cancer Cells.

Journal of natural products·2025
Same author

Deoxygenative Difunctionalization of Aldehydes via Ketyl Radical and Light/Dark Pd Synergy.

Angewandte Chemie (International ed. in English)·2025
Same author

Proximity-based proteomics (BioID) uncovers the Rho GTPase interactome in kidney podocytes.

Frontiers in cell and developmental biology·2025

Researchers developed new cannabinergic ligands, C1'-azacycloalkyl hexahydrocannabinols. The N-methylazetidinyl and N-methylpyrrolidinyl analogues show high affinity for CB1 and CB2 cannabinoid receptors.

Area of Science:

  • Medicinal Chemistry
  • Organic Synthesis
  • Pharmacology

Background:

  • Cannabinoid receptors (CB1 and CB2) are key targets for therapeutic interventions.
  • Developing novel ligands with specific affinities is crucial for understanding cannabinoid signaling.
  • Existing synthetic routes may lack efficiency or versatility for creating diverse analogues.

Purpose of the Study:

  • To design and synthesize a novel class of hexahydrocannabinol derivatives with azacycloalkyl substituents at the C1' position.
  • To establish efficient synthetic methodologies for accessing these novel compounds.
  • To evaluate the biological activity and receptor binding affinity of the synthesized ligands for CB1 and CB2 receptors.

Main Methods:

  • Utilized a common chiral intermediate triflate for the synthesis of diverse analogues.

Related Experiment Videos

  • Employed microwave-assisted Liebeskind-Srogl C-C cross-coupling for key bond formations.
  • Applied palladium-catalyzed decarboxylative coupling reactions in the synthetic strategy.
  • Main Results:

    • Successfully synthesized a novel series of C1'-azacycloalkyl hexahydrocannabinols.
    • Identified C1'-N-methylazetidinyl and C1'-N-methylpyrrolidinyl analogues as high-affinity ligands.
    • Demonstrated high binding affinity for both CB1 and CB2 cannabinoid receptors by these specific analogues.

    Conclusions:

    • The developed synthetic routes provide a versatile platform for generating novel cannabinergic ligands.
    • The novel C1'-azacycloalkyl hexahydrocannabinols represent a promising class of compounds for modulating cannabinoid receptor activity.
    • These findings contribute to the development of targeted therapeutics within the cannabinoid system.